Jane Howard

24 papers receiving 855 citations

Peers

Jane Howard
Comparison fields: 5 of 58
  • Otorhinolaryngology 94
  • Cancer Research 213
  • Oncology 212
  • Geriatrics and Gerontology 31
  • Radiology, Nuclear Medicine and Imaging 137
Replace Elżbieta Nowara with:
Elżbieta Nowara Poland
Sarah LeNoir Sammons United States
Joan E. Trey United States
Chantal Bernard-Marty Belgium
Moshe Itzhaki France
Thomas R. Buroker United States
Sara Donati Italy
Swantje Held Germany
Qian Dong China
Brent O’Carrigan United Kingdom
Jane Howard relative to Elżbieta Nowara Poland Elżbieta Nowara's profile →
Citations per field
00.5×5×10×15.5×
Elżbieta Nowara · 1×
Citations per year

Countries citing papers authored by Jane Howard

Since Specialization
Citations

This map shows the geographic impact of Jane Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Howard more than expected).

Fields of papers citing papers by Jane Howard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Howard. The network helps show where Jane Howard may publish in the future.

Co-authors

The 25 scholars most cited alongside Jane Howard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jane Howard Line = papers co-authored together Jane Howard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#Work
1
cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer.
1980106
2 2010105
3 201181
4
Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
198076
5 201173
6
Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer.
198368
7 202058
8 201253
9 200541
10 201536
11 201234
12 200526
13
cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomas.
197822
14 202122
15 202021
16 202120
17 198318
18
Phase II trial of methyl-GAG in advanced renal cancer.
198116
19 202214
20 200513

About Jane Howard

Jane Howard is a scholar working on Cancer Research, Geriatrics and Gerontology, Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 933 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Extracellular vesicles in disease (5 papers), Frailty in Older Adults (3 papers), Cancer Treatment and Pharmacology (3 papers), Medical Imaging Techniques and Applications (2 papers), Head and Neck Cancer Studies (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Otorhinolaryngology (94 citations), Cancer Research (213 citations), Oncology (212 citations), Geriatrics and Gerontology (31 citations) and Radiology, Nuclear Medicine and Imaging (137 citations). Jane Howard has collaborated with scholars based in United States, Ireland and Spain. Frequent co-authors include Clifford A. Hudis, Sujata N Patil, Patrick Glyn Morris, Heather L. McArthur, Amanda H McCann, Charles W. Young, Maura N. Dickler, Larry Norton, Maxine S. Jochelson and Steven M. Larson. Their work appears in journals such as Cancer, The Breast Journal, Scientific Reports, Drugs & Aging and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact